These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2005-002355-40||An open randomized phase III trial of six cycles of docetaxel versus surveillance after radical prostatectomy in prostate cancer patients with high grade pT3 or margin positive pT2||not-yet-due|
|Ongoing||2006-001657-94||A randomised adjuvant Phase III Trial of six cycles of docetaxel and hormonal treatment versus hormonal treatment in patients with intermediate or high-risk prostate cancer treated with radical radiot...||not-yet-due|
|Ongoing||2008-003138-33||A Randomized, Open Label, Phase III, Multicenter, 2-Arm Study of Androgen deprivation +/- Taxotere (Docetaxel) for Non metastatic Prostate Cancer Patients with a Rising PSA.||not-yet-due|
|Ongoing||2011-003078-10||SPCG 16 Sensi-cab Randomized phase III trial comparing cabazitaxel in combination with hormone therapy to hormone therapy alone in metastatic prostate cancer||not-yet-due|